Liver Transplantation

Liver Transplantation at Baylor:
Disease-Specific Results and Long-Term Outcomes

Robert M. Goldstein

Table 4. Comparison of hepatitis C-positive and -negative donors for patients who are hepatitis C-positive and the recurrence of hepatitis C posttransplant

Donor Group	Survival (no./%)	Recurrence* (no./%)	Mean Time to Recurrence	Early Acute Rejections**
HCV+ n=14	5/100	2/16.9	4.85±0.2 mos	9/14 (64.3%)
HCV- n=58	23/89.1	22/50.0	9.25±0.5 mos	34/53 (64.2%)

* Values at one year with number recurring and probability percent.
** Number with at least one episode within three months.

Go to top · Return to Chapter · Return to Table of Contents

Please be aware that medical advice, diagnoses and physician references cannot be obtained from this site.